Angiotensin 2 Receptor Blocker — Patent Landscape

Aggregated US Orange Book patent estate across every drug in the angiotensin 2 receptor blocker class. 2 active patents protecting 1 drugs. First major cliff: 2041. Daily refresh.

1
Drugs in class
2
Active US patents
65/100
Avg vulnerability
—
Annual revenue covered

Originators

Merck & Co. 2 patents

Cliff calendar — next 15 years

No expiries in next 15 years.

Drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Cozaar
LOSARTAN POTASSIUM
 Merck & Co. 2 65 — 2041-10-07

Most attackable patents

Patent Drug Type Vuln Expiry
12156869 Cozaar method of use 75 2041-10-07
11890273 Cozaar formulation 55 2041-10-07

Strongest defences

Patent Drug Type Vuln Expiry
11890273 Cozaar formulation 55 2041-10-07
12156869 Cozaar method of use 75 2041-10-07

Related